Literature DB >> 27836433

Sex differences in the epidemiology, clinical features, and pathophysiology of migraine.

Kjersti Grøtta Vetvik1, E Anne MacGregor2.   

Abstract

Migraine is two to three times more prevalent in women than men, and women report a longer attack duration, increased risk of headache recurrence, greater disability, and a longer period of time required to recover. Conditions recognised to be comorbid with migraine include asthma, anxiety, depression, and other chronic pain conditions, and these comorbidities add to the amount of disability in both sexes. Migraine-specifically migraine with aura-has been identified as a risk factor for vascular disorders, particularly in women, but because of the scarcity of data, the comparative risk in men has yet to be established. There is evidence implicating the role of female sex hormones as a major factor in determining migraine risk and characteristics, which accounts for sex differences, but there is also evidence to support underlying genetic variance. Although migraine is often recognised in women, it is underdiagnosed in men, resulting in suboptimal management and less participation of men in clinical trials.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27836433     DOI: 10.1016/S1474-4422(16)30293-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  121 in total

Review 1.  Women and Migraine: the Role of Hormones.

Authors:  Candice Todd; Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-31       Impact factor: 5.081

2.  Sex differences in brain metabolic activity: Beyond the concept of brain age.

Authors:  Ewelina Biskup; Frances-Catherine Quevenco; Maria Teresa Ferretti; Antonella Santuccione-Chadha
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

3.  Gender differences in migraine.

Authors:  Maria Clara Tonini
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 4.  Impact of Conventional Stroke Risk Factors on Stroke in Women: An Update.

Authors:  Tracy E Madsen; Virginia J Howard; Monik Jiménez; Kathryn M Rexrode; Maria Czarina Acelajado; Dawn Kleindorfer; Seemant Chaturvedi
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

5.  Migraine with aura and white matter lesions: an MRI study.

Authors:  Carla Uggetti; Silvia Squarza; Fabio Longaretti; Alberto Galli; Paola Di Fiore; Paolo Filippo Reganati; Adriana Campi; Andreana Ardemagni; Maurizio Cariati; Fabio Frediani
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

6.  Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network.

Authors:  Lanfranco Pellesi; Sabina Cevoli; Valentina Favoni; Chiara Lupi; Edoardo Mampreso; Andrea Negro; Antonio Russo; Silvia Benemei; Simona Guerzoni
Journal:  Neurol Sci       Date:  2019-11-13       Impact factor: 3.307

Review 7.  Neurogenic inflammation and its role in migraine.

Authors:  Roshni Ramachandran
Journal:  Semin Immunopathol       Date:  2018-03-22       Impact factor: 9.623

Review 8.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 9.  Targeting BKCa Channels in Migraine: Rationale and Perspectives.

Authors:  Mohammad Al-Mahdi Al-Karagholi; Christian Gram; Cherie Amalie Waldorff Nielsen; Messoud Ashina
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

10.  Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Rebecca M Craft; Michael M Morgan
Journal:  Eur J Pharmacol       Date:  2017-10-28       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.